These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16879406)

  • 1. p63 expression correlates with pathological features and biological behaviour of odontogenic tumours.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Giannone N; Carinci F; Leonardi R; Lanzafame S; Piattelli A
    Histopathology; 2006 Aug; 49(2):211-4. PubMed ID: 16879406
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of p63 in thymomas and normal thymus.
    Dotto J; Pelosi G; Rosai J
    Am J Clin Pathol; 2007 Mar; 127(3):415-20. PubMed ID: 17276940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High DeltaN p63 isoform expression favours recurrences in odontogenic keratocyst--odontogenic keratocystic tumour.
    Foschini MP; Cocchi R; Marucci G; Pennesi MG; Magrini E; Ligorio C; Lombardini F; Tosi AL; Marchetti C
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):673-5. PubMed ID: 16687239
    [No Abstract]   [Full Text] [Related]  

  • 4. p63 expression in odontogenic cysts.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Fior A; Trevisiol L; Carinci F; Leonardi R; Bufo P; Lanzafame S; Piattelli A
    Int J Oral Maxillofac Surg; 2005 Sep; 34(6):668-73. PubMed ID: 16053892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of deltaNp63 in salivary gland tumours].
    He ZX; Li YN; Liu LK; He HW; Wang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):126-8. PubMed ID: 16468660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
    de Oliveira LR; Ribeiro-Silva A; Zucoloto S
    J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors.
    Li H; Cherukuri P; Li N; Cowling V; Spinella M; Cole M; Godwin AK; Wells W; DiRenzo J
    Cancer Res; 2007 Jan; 67(2):501-10. PubMed ID: 17234757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p63 gene expression study and early bladder carcinogenesis.
    Compérat E; Bièche I; Dargère D; Ferlicot S; Laurendeau I; Benoît G; Vieillefond A; Verret C; Vidaud M; Capron F; Bedossa P; Paradis V
    Urology; 2007 Sep; 70(3):459-62. PubMed ID: 17905096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p63 expression in ovarian tumours: immunopositivity in metastatic transitional cell carcinoma of the ovary.
    Kalebi A; Hale M
    Histopathology; 2008 Aug; 53(2):228. PubMed ID: 18518899
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of Ki-67, p53 and p63 proteins in keratocyst odontogenic tumours: an immunohistochemical study.
    Gurgel CA; Ramos EA; Azevedo RA; Sarmento VA; da Silva Carvalho AM; dos Santos JN
    J Mol Histol; 2008 Jun; 39(3):311-6. PubMed ID: 18256893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma.
    Vered M; Allon I; Dayan D
    J Oral Pathol Med; 2009 Mar; 38(3):314-20. PubMed ID: 18783348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ameloblastoma, calcifying epithelial odontogenic tumor, and glandular odontogenic cyst show a distinctive immunophenotype with some myoepithelial antigen expression.
    Gratzinger D; Salama ME; Poh CF; Rouse RV
    J Oral Pathol Med; 2008 Mar; 37(3):177-84. PubMed ID: 18251942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of hMLH1, p63, and MDM2 proteins in the pathogenesis of syndromic and nonsyndromic keratocystic odontogenic tumors.
    de Brito Monteiro BV; Cavalcante RB; Maia Nogueira RL; da Costa Miguel MC; Weege Nonaka CF; da Silveira ÉJ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jul; 120(1):52-7. PubMed ID: 25957541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analyses of p63 expression in cutaneous tumours.
    Takeuchi Y; Tamura A; Kamiya M; Fukuda T; Ishikawa O
    Br J Dermatol; 2005 Dec; 153(6):1230-2. PubMed ID: 16307669
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of p63 normal canine skin and primary cutaneous glandular carcinomas.
    Saraiva AL; Gärtner F; Pires MA
    Vet J; 2008 Jul; 177(1):136-40. PubMed ID: 17804265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p63 in cutaneous metastases.
    Kanitakis J; Chouvet B
    Am J Clin Pathol; 2007 Nov; 128(5):753-8. PubMed ID: 17951196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p63 in Primary Cutaneous Carcinosarcoma.
    Suh KY; Lacouture M; Gerami P
    Am J Dermatopathol; 2007 Aug; 29(4):374-7. PubMed ID: 17667171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of p63 isoforms in normal skin and hyperproliferative conditions.
    Kim SY; Cho HJ; Kim DS; Choi HR; Kwon SB; Na JI; Jeon HC; Huh CH; Youn SW; Cho KH; Park KC
    J Cutan Pathol; 2009 Aug; 36(8):825-30. PubMed ID: 19586494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perlecan-rich epithelial linings as a background of proliferative potentials of keratocystic odontogenic tumor.
    Tsuneki M; Cheng J; Maruyama S; Ida-Yonemochi H; Nakajima M; Saku T
    J Oral Pathol Med; 2008 May; 37(5):287-93. PubMed ID: 18205742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells.
    Yang A; Zhu Z; Kapranov P; McKeon F; Church GM; Gingeras TR; Struhl K
    Mol Cell; 2006 Nov; 24(4):593-602. PubMed ID: 17188034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.